SLN | Silence Therapeutics Plc American Depository ShareNASDAQHealthcareADR golden cross and death cross projections, cross tests and history

$19.76
+$0.01 (+0.05%)

Silence Therapeutics Plc American Depository Share (SLN) is a NASDAQ-listed ADR that Cruxta has tracked for 50/200 crosses since 2022.

The 50 SMA has sat above the 200 on the daily since Apr 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour. On the weekly a golden cross is projected within 10 bars.

Timeframe summary

Daily as of 2 Nov 16:00 ET

Price
above both $19.76 vs 50 $13.61 / 200 $9.13
Projection
No cross projected
Test
No active test
Last cross
Golden cross 22 Apr 2026 ยท projected 21 bars out

Weekly as of 30 Oct 16:00 ET

Price
above both $19.75 vs 50 $8.47 / 200 $10.50
Projection
Golden cross projected in 10 bars
Test
No active test
Last cross
Death cross week of 3 Mar 2025 ยท projected 23 bars out

4-hour as of 3 Nov 16:00 ET

Price
above both $19.78 vs 50 $14.55 / 200 $12.31
Projection
No cross projected
Test
No active test
Last cross
Golden cross 25 Mar 2026 ยท projected 26 bars out

Cross history

16
crosses on record since 2022
8 golden8 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
22 Apr 2026Golden moderatedaily21 bars outNot tested
25 Mar 2026Golden4-hour26 bars outNot tested
18 Feb 2026Death moderatedaily23 bars out2 bar cross test
21 Jan 2026Death4-hour22 bars out1 bar cross test
23 Oct 2025Golden4-hour29 bars outNot tested

About SLN

ExchangeNASDAQ
InstrumentADR
Median $ volume, 60 d$11.2M
4-hour coverageYes, since Oct 2025
History on recordSince 2022
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.